Background: By assaying hundreds of thousands of single nucleotide polymorphisms, genome wide association studies (GWAS) allow for a powerful, unbiased review of the entire genome to localize common genetic variants that influence health and disease. Although it is widely recognized that some correction for multiple testing is necessary, in order to control the family-wide Type 1 Error in genetic association studies, it is not clear which method to utilize. One simple approach is to perform a Bonferroni correction using all n single nucleotide polymorphisms (SNPs) across the genome; however this approach is highly conservative and would "overcorrect" for SNPs that are not truly independent. Many SNPs fall within regions of strong linkage disequilibrium (LD) ("blocks") and should not be considered "independent".
Background
Since first proposed in 1996 by Risch and Merikangas [1] , it has increasingly been accepted that association studies are powerful to detect modest effects of common alleles involved in complex trait susceptibility. Until recently, genotype-phenotype tests of association have been limited to candidate genes. Recent advances in molecular technologies and the availability of the human genome sequence have revolutionized researchers' ability to catalogue human genetic variation. In addition, the International HapMap project has provided researchers with invaluable information regarding the linkage disequilibrium (LD) structure within the genome [2, 3] . These advances have made genome wide association studies (GWAS) to identify common variants a reality. However many issues regarding the design, analysis and interpretation of results remain to be investigated.
In particular, interpretation of results is not trivial in light of the scale of multiple testing proposed. Testing such a large number of SNPs will require a balance between power and the chance of making false discoveries. There are many methods that have been proposed to address the multiple testing issue. These include false discovery rate (FDR), permutation testing, Bayesian factors (BF) and the Bonferonni correction. The FDR controls the expected proportion of false positives among all rejections, providing a less stringent control of the Type I error [4] . The application of the FDR method specifically in the context of genome wide studies has been proposed [4] [5] [6] . Permutation testing, in which the datasets are permuted thousands of times to achieve genomewide significance is another method that has been used in candidate gene studies and now genome wide association studies [7, 8] . Although empirical p-values have a theoretical advantage they may be computationally infeasible with large datasets. Another proposed method is the use of Bayesian Factors (BF) instead of frequentist p-values which need to be interpreted with the power of the study. However, BF also requires an assumption about the effect size, but the major advantage is that it can be compared across studies [9] . A simple method to control the family-wise error rate is the Bonferroni correction, which adjusts the Type 1 error (a) by the total number of tests (a/n). The Bonferroni correction can use the actual number of tests performed (i.e. SNPs genotyped) or a theoretical value based on the total number of tests possible (i.e. all SNPs). One critical, but often overlooked, assumption, of the Bonferroni correction method, is the assumption that all the tests are independent [10] . Biologically, we know that SNPs in close proximity are not independent, and therefore we are "overcorrecting" when we use the traditional Bonferroni method to adjust significance thresholds for multiple testing in GWAS studies [11] . We propose Bonferroni corrected p-value thresholds that account for the interdepdendence of SNPs on commonly used commercially available SNP "chips" (Illumina 317 K and Affymetrix 500 K) and in the HapMap panels. This method is an extension of the Bonferroni correction that accounts for the underlying linkage disequilibrium or dependence in dense SNP panels. These thresholds will be invaluable to researchers as they can be used as a guide to identifying regions of interest or significance in genome wide association studies, which should be studied further.
Methods
In order to estimate the effective number of "independent" SNPs in 3 autosomal marker panels (HapMap, Illumina 317 K and Affymetrix 500 K) we downloaded genotype data from release 22 of the International Hap-Map project. We used the non-redundant CEU and YRI data mapped against the "rs strand" of build 36 of the human genome. For the Illumina and Affymetrix marker sets we used a perl script to generate chromosome specific files containing only the subset of specific markers included in the Illumina 317 K or Affymetrix 500 K panels using CEU data. Then for each chromosome of data we used a perl script to generate smaller more manageable files each containing genotype data for approximately 2500 SNPs. We used Haploview version 4.0 to evaluate blocks of linkage disequilibrium (LD) using the 'Solid Spine of LD' algorithm with a minimum D' value of 0.8. The Solid Spine of LD method internal to Haploview defines a block when the first and last markers are in strong LD with all intermediate markers. We also evaluated chromosome 1 for the CEU HapMap data using the "Solid Spine of LD' algorithm and varying the minimum D' value to 0.7 and 0.9 to determine if this value altered the thresholds. In addition, we evaluated chromosome 1 for the CEU HapMap data using the Gabriel and 4-gamete block defining methods. For all analyses we ignored pairwise comparisons of markers >500 kb apart and excluded individuals with >50% missing genotypes. We also excluded markers with a minor allele frequency less than 0.01, a Hardy-Weinberg equilibrium p-value less than 0.001 or a genotype call rate less than 75%. We then summarized across the genome: Total number of SNPs, Total number of Blocks, Total number of SNPs not in a block (inter-block SNPs) and Total number of blocks + interblock SNPs for each panel. Our programs are available upon request so that thresholds can be established per population.
Results and discussion
We established three thresholds that correspond to 1) suggestive association in which we expect 1 false positive association per GWAS 2) significant association in which we expect one false positive association to occur 0.05 times per GWAS and 3) highly significant association in which we expect one false positive association to occur 0.001 times per GWAS. In the CEPH Utah (CEU) population, by considering the interdependence of SNPs, we reduced the total number of effective tests within the Affymetrix and Illumina SNP panels from 500,000 and 317,000 to 67,000 and 82,000 "independent" SNPs, respectively (Tables 1 and 2 ). This results in p-value thresholds of ≈10 -5 , 10 -7 and 10 -8 for both the Affymetrix and Illumina SNP panels (Table 3 ) compared to ≈10 -6 , 10 -7 and 10 -9 if we do not correct for the lack of independence among SNPs. For researchers using these set genome-wide SNP panels this provides valuable thresholds to interpret association results, and to identify SNPs that may be important for replication.
In addition to the established SNP panels, we evaluated the number of "independent" tests within the Phase II HapMap publicly available data for both the CEPH from Utah (CEU) and Yoruba (YRI) populations. Since our proposed thresholds are LD block dependent, they are population specific and the total number of "independent" SNPs may vary across populations and therefore should be considered separately. The publicly available data includes 2.4 million (CEU) and 2.7 million (YRI) SNPs across the genome. We reduced the total number of tests to 164,000 SNPs and 289,000 SNPs for the CEU and YRI, respectively (Tables 4 and 5 ). This results in p-value thresholds of ≈10-6, 10-7 and 10-9 for both the CEU and YRI populations (Table 3 ) compared to ≈10-7, 10-8 and 10-10 if we do not correct for the lack of independence among SNPs. The total number of "independent" SNPs for the YRI population is nearly double that for the CEU, however this does not have an impact on the exponent of the p-value. As expected, as the density of SNPs increases, the average number of SNPs within a block also increases. Therefore, it is likely that the additional Affymetrix and Illumina SNP panels (1 million and 650,000 SNPs) will not greatly increase the number of independent SNPs but will increase the number of SNPs within a block. However, using the highly dense HapMap population (Tables 4 and 5) provides us with thresholds that can be used for denser platforms (e.g. 1 million SNPs) or for studies that utilize statistical methods to impute the 2.5 million+ HapMap SNPs.
We also altered the D' value used to define the blocks from 0.7 to 0.9 for Chromosome 1 in the HapMap CEU population to determine if block definition had a large impact on our results. Using a D' value of 0.7 results in 2,039 fewer "independent" SNPs on chromosome 1 which extrapolates to 44,000 fewer "independent" SNPs across the genome. Using a more stringent value of D' = 0.9 results in 2,906 more "independent" SNPs on chromo- 1  31876  4447  833  5280  2  33610  4626  787  5413  3  27588  3903  723  4626  4  25811  3514  689  4203  5  26548  3601  646  4247  6  26550  3487  604  4091  7  21544  3061  618  3679  8  22550  3053  563  3616  9  19086  2664  541  3205  10  23531  3046  510  3556  11  21477  2761  528  3289  12  20549  2821  499  3320  13  15700  2116  392  2508  14  12839  1820  371  2191  15  11560  1857  396  2253  16  12339  1944  454  2398  17  8473  1385  344  1729  18  11966  1748  374  2122  19  5177  954  305  1259  20  10292  1519  331  1850  21  5873  843  204  1047  22  5053  828  213  1041 Total 399,992 55,998 10,925 66,923 some 1 which extrapolates to 63,932 more "independent" SNPs across the genome. Although this may increase the range of total SNPs across the genome from 120,000 to 228,000 it does not alter the exponent of the p-value or substantially affect the thresholds (Table 3) .
We also defined blocks using two additional block definitions: the Gabriel method and the 4-gamete rule. The Gabriel method creates blocks using stringent criteria of LD with a D' upper bound >0.98 and a lower bound >0.70 [12] . This creates smaller blocks with fewer SNPs within a block. The 4-gamete rule of Wang, based on Hudson and Kaplan determines blocks based on presumed recombination [13, 14] . Using pairwise sets of SNPs it determines the frequency of observing all 4 possible 2-SNP haplotypes. If all 4 haplotypes are observed, this method assumes recombination has occurred. Table 6 shows the results of different block definitions for Chro- 3097  918  4015  13  11411  2373  620  2993  14  9767  2086  592  2678  15  8817  1942  631  2573  16  8924  2078  705  2783  17  8279  1859  603  2462  18  10390  2183  678  2861  19  5833  1408  545  1953  20  7758  1736  496  2232  21  5430  1130  318  1448  22  5398  1156  379  1535 Total 305,008 64,494 18,000 82,494 mosome 1 for the CEU HapMap samples. The Gabriel method results in a similar number of blocks, but the number of SNPs per block is greatly reduced resulting in more SNPs outside of the block that are still in LD but do not meet the stringent criteria of a "block". The 4-gamete rule results in fewer blocks and more SNPs outside of blocks that represent potential recombination events. To limit the dependence on LD we believe the solid spine of LD is the best method to capture the underlying LD and biological dependence of SNPs, and therefore we base our thresholds on this method.
The method we detail is an extension to the original Bonferroni correction which is widely utilized; however, we have reduced the total number of SNPs to reflect the number of "independent SNPs" since independence is an assumption of the Bonferroni correction. Therefore, our thresholds are based on the original Bonferroni calculation of 1/Total # of SNPs, 0.05/Total # of SNPs and 0.001/ Total # of SNPs where the number of SNPs that we use is now a better estimate of the number of independent tests being performed. Therefore, our proposed method allows a Bonferroni correction that has less violation of the assumption of independence.
We have empirically defined thresholds for genome wide association studies to control the family-wise error rate while accounting for the interdependence of SNPs in linkage disequilibrium. The use of actual data provides us an opportunity to unequivocally characterize the underlying linkage disequilibrium structure in these two populations.
We considered the use of simulations as has been done for single chromosomes by assigning haplotypes based on frequencies from inferred haplotypes of founders for a set number of replicates [11] . But the reality is that simulation programs have thus far been unable to recreate the complexity of the underlying LD structure of the human genome. While we could use real 500 K genotype data and simulate unassociated traits, we would need to obtain many real 500 K GWAS data sets and then simulate many replicates of unassociated traits in each of them to adequately examine Type I error. Currently, this is a daunting task since the process just for obtaining the data from public databases is quite lengthy and the analysis time required to perform hundreds of GWAS analyses would be prohibitive.
By identifying the "independent" SNPs, we have significantly reduced the total number of SNPs to be used for Bonferroni correction in the set of SNP panels (Affymetrix and Illumina) and in HapMap. These "independent" SNPs provide us with a more accurate number of SNPs to include when adjusting for multiple testing using the Bonferroni correction. In addition, these p-values can assist in 1  184403  10740  1815  12555  2  211913  11219  1510  12729  3  166801  9431  1426  10857  4  155953  10204  1745  10363  5  161666  8725  1238  9963  6  174458  8677  1743  10420  7  137148  8050  1140  9190  8  141925  7707  1076  8783  9  116824  7092  1105  8197  10  132087  7428  1250  8607  11  124354  6821  1037  7858  12  118973  6959  991  7950  13  99669  5290  793  6083  14  80500  4690  893  5583  15  69104  4690  814  5504  16  68205  5212  817  6029  17  56026  4127  715  4842  18  73392  4486  742  5228  19  35412  3109  570  3679  20  60421  3896  606  4502  21  32740  2141  380  2521  22  33369  2491  421  2853   Total  2,435,343  143,185  22,827  164,296 determining power for GWAS prior to genotyping so that only studies which can attain suggestive or significant association are pursued. We acknowledge that although we reduce the number of independent SNPS, the corresponding p-value cutoffs are still very low because we are analyzing more than 2 million SNPs without a specific biological hypothesis and stringency is still important. We need to balance identifying a true association while limiting Type 1 error.
We did evaluate the effects of the new thresholds on power using the Genetic Power Calculator to [15] determine the sample sizes we would need using a significance level based on all HapMap SNPs versus only the independent SNPs and blocks, as we recommend here. Table   7 provides different sample sizes using the 'LD adjusted' Bonferroni correction that we suggest here and the unadjusted Bonferroni correction in both CEU and YRI Hap-Map samples. Using the unadjusted Bonferroni correction would result in a necessary increase in sample size of 358-890 cases depending on the genotype relative risk and population. This increased burden of sample recruitment, collection and genotyping to adjust for "all" SNPs needs to be considered carefully, especially since many of the SNPs will be in strong LD and not contributing increased information. thresholds of significance, similar to those established by Lander and Kruglyak for LOD score genetic linkage analyses [16] . The dilemma facing many researchers is which regions to follow-up with dense SNPs or sequencing? To date, the most utilized threshold has been the arbitrary value set by the Wellcome Trust Case Control Consortium of 5 × 10 -7 [17] . Interestingly, our Bonferroni LD-adjusted values are similar to these two thresholds (nominal pvalue = 3.04 × 10 -7 for CEU), but we also provide thresholds for suggestive and highly significant association. We believe the suggestive association threshold should be used to identify SNPs for consideration in follow-up studies, and both the significant and highly significant associations should be considered regions more likely of association. Of course, these thresholds are only guidelines that account for the interdependency of SNPs and investigators should carefully consider any regions with strong candidate genes or biologic plausibility even if they do not meet these thresholds. We also agree with the NHGRI/ NCI working group on Replication in Association Studies that all statistically significant regions should be replicated using additional populations with adequate sample size to confirm any GWAS finding [18] . These thresholds should assist in replicating regions of true association.
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